{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:24:36Z","timestamp":1789885476185,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.critrevonc.2014.10.008","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T17:17:50Z","timestamp":1413998270000},"page":"246-256","source":"Crossref","is-referenced-by-count":20,"title":["Hepatitis C virus and lymphoma"],"prefix":"10.1016","volume":"93","author":[{"given":"Semra","family":"Paydas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2014.10.008_bib0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/gut.2009.192088","article-title":"Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes","volume":"59","author":"Durand","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0020","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3748\/wjg.v13.i17.2467","article-title":"Hepatitis C virus-related lymphoproliferative disorders: an overview","volume":"13","author":"Zignego","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-116-2-97","article-title":"Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study","volume":"116","author":"Simonetti","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-117-7-573","article-title":"Hepatitis C virus infection in patients with essential mixed cryoglobulinemia","volume":"117","author":"Misiani","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0035","first-page":"621","article-title":"Association between hepatitis C virus and mixed cryoglobulinemia","volume":"9","author":"Ferri","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s007050050100","article-title":"Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role","volume":"142","author":"Zignego","year":"1997","journal-title":"Arch Virol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.25499","article-title":"Hepatitis C and non-Hodgkin lymphoma: the clinical perspective","volume":"55","author":"Hartridge-Lambert","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1994.03520050033023","article-title":"Non-Hodgkin's lymphoma: possible role of hepatitis C virus","volume":"272","author":"Ferri","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.20205","article-title":"B-cell non-Hodgkin's lymphoma hepatitis C virus infection: a systematic review","volume":"111","author":"Negri","year":"2004","journal-title":"Int Cancer J"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0060","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0065","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Lowgrade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","article-title":"Hepatitis C virus infection in patients with non-Hodgkin's lymphoma","volume":"88","author":"Ferri","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","article-title":"Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study","volume":"102","author":"Mele","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20608","article-title":"Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection","volume":"41","author":"Duberg","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0085","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1158\/1055-9965.EPI-08-0408","article-title":"Hematopoietic malignancies associated with viral and alcoholic hepatitis","volume":"17","author":"Anderson","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0090","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20137","article-title":"Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy","volume":"110","author":"Talamini","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1055-9965.425.13.3","article-title":"Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women","volume":"13","author":"Morton","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10552-009-9316-0","article-title":"Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes","volume":"20","author":"Goldman","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0125","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/ijc.23416","article-title":"Hepatitis C infection and risk of malignant lymphoma","volume":"122","author":"Sch\u20acollkopf","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0130","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/ijc.26283","article-title":"Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study","volume":"130","author":"Omland","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12185-008-0086-3","article-title":"Risk of malignant lymphoma following viral hepatitis infection","volume":"87","author":"Cocco","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2169\/internalmedicine.39.112","article-title":"Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma","volume":"39","author":"Mizorogi","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7150\/ijms.3.41","article-title":"Epidemiology of hepatitis C virus (HCV) infection","volume":"3","author":"Sy","year":"2006","journal-title":"Int J Med Sci"},{"issue":"11","key":"10.1016\/j.critrevonc.2014.10.008_bib0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4254\/wjh.v3.i11.278","article-title":"Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma","volume":"3","author":"Pellicelli","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0155","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.1995.tb05582.x","article-title":"Clonal B-cell expansions in peripheral blood of HCV infected patients","volume":"90","author":"Franzin","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0170","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0175","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/807351","article-title":"Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis","author":"Forghieri","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2013.101600","article-title":"Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients","volume":"99","author":"Morton","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2141.1996.6912313.x","article-title":"Hepatitis C virus and non-Hodgkin's lymphomas","volume":"94","author":"Mazzaro","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0195","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bjc.6690522","article-title":"Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey","volume":"80","author":"Paydas","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10386","article-title":"Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma","volume":"74","author":"Paydas","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0205","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood-2002-08-2424","article-title":"Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas","volume":"101","author":"Greeve","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0167-5699(00)01605-4","article-title":"CD27: a memory B-cell marker","volume":"21","author":"Agematsu","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/jir.2009.0047","article-title":"Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients","volume":"30","author":"Mizuochi","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0220","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2005.12.039","article-title":"Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism","volume":"130","author":"Pal","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0225","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.20092","article-title":"Detection of hepatitis C virus RNA in paraffin-embedded tissues from patients with non-Hodgkin's lymphoma","volume":"76","author":"Paydas","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ijc.20021","article-title":"Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study","volume":"111","author":"Engels","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0235","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2362.1997.1790728.x","article-title":"Viruses and cancers: possible role of hepatitis C virus","volume":"27","author":"Ferri","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0240","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.1997.4023216.x","article-title":"Hepatitis C virus-related lymphomas","volume":"99","author":"Silvestri","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J Hepatol"},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2014.10.008_bib0250","first-page":"19","article-title":"Helicobacter and gastric MALT lymphoma","volume":"50","author":"Stolte","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0265","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell non-Hodgkin's lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0270","first-page":"128","article-title":"Hematological response to antiviral therapy in 94 patients with indolent B-cell lymphomas associated with hepatitis C virus infection: a study of the Fondazione Italiana Linfomi (FIL)","volume":"22","author":"Arcaini","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0275","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","article-title":"Infection of peripheral mononuclear blood cells by hepatitis C virus","volume":"15","author":"Zignego","year":"1992","journal-title":"J Hepat"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0280","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","article-title":"Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia","volume":"82","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/835314","article-title":"HCV infection and B-cell lymphomagenesis","author":"Ito","year":"2011","journal-title":"Adv Hemat"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","author":"Zignego","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0300","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/infdis\/171.3.672","article-title":"Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C","volume":"171","author":"Galli","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0305","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0310","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0315","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clim.2010.02.002","article-title":"Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients","volume":"135","author":"Ito","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/167501","article-title":"Hepatitis C virus-related lymphomagenesis in a mouse model","author":"Tsukiyama-Kohara","year":"2011","journal-title":"ISRN Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0330","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.leu.2400869","article-title":"The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma","volume":"11","author":"Silvestri","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0335","first-page":"351","article-title":"Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia","volume":"10","author":"Luppi","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-8652(199706)55:2<77::AID-AJH5>3.0.CO;2-#","article-title":"High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy","volume":"55","author":"De Rosa","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0345","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<95::AID-AJH4>3.0.CO;2-A","article-title":"Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma","volume":"64","author":"Pioltelli","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0350","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","article-title":"Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo","volume":"116","author":"Kasama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0355","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cancergencyto.2007.09.009","article-title":"Random aneuploidy in chronic hepatitis C patients","volume":"180","author":"Goldberg-Bittman","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0365","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1128\/JVI.02643-08","article-title":"Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway","volume":"83","author":"Machida","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?","volume":"8","author":"De Vita","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0375","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2013-10-532895","article-title":"B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0091373","article-title":"B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-Kb signalling","volume":"9","author":"Kasama","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0385","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2014-202352","article-title":"MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma","volume":"67","author":"Augello","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0390","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.160.7.3594","article-title":"Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia","volume":"160","author":"Sansonno","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/eji.200324328","article-title":"Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection","volume":"34","author":"Sansonno","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0400","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3892\/ijo_00000618","article-title":"Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?","volume":"36","author":"Libra","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0405","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdl131","article-title":"Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy","volume":"17","author":"Visco","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0410","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/10428190701732861","article-title":"Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma","volume":"49","author":"Park","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0415","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archophthalmol.2010.233","article-title":"Hepatitis C virus infection in ocular adnexal lymphomas","volume":"128","author":"Strianese","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0420","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C viruspositive patients in LNH 93 and LNH 98 groupe d\u2019etude des lymphomes de l\u2019adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0425","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.10.008_bib0430","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcv.2012.03.002","article-title":"Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study","volume":"54","author":"Torres","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0435","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-128-7-199804010-00027","article-title":"Hepatitis C virus genotype distribution in B-cell non-Hodgkin lymphoma","volume":"128","author":"Luppi","year":"1998","journal-title":"Ann Int Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0440","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjmed.2007.06.022","article-title":"Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C","volume":"120","author":"Kawamura","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0445","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0450","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0455","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2011.01.028","article-title":"The results of phase III clinical trials with telaprevir and boceprevir presented at the liver meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending","volume":"140","author":"Pawlotsky","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0460","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2005.02395.x","article-title":"Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection","volume":"21","author":"Gisbert","year":"2005","journal-title":"Alim Pharmacol Ther"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0465","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0470","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2008.06.025","article-title":"Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma","volume":"49","author":"La Mura","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0475","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/1042819031000083055","article-title":"Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma","volume":"44","author":"Tomita","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0480","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.clml.2011.04.005","article-title":"Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature","volume":"11","author":"Nooka","year":"2011","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0485","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4251\/wjgo.v4.i3.46","article-title":"HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: evidence and open questions","volume":"15","author":"Cox","year":"2012","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0490","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.2013.094318","article-title":"Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi","volume":"99","author":"Merli","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0495","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.21564","article-title":"Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas","volume":"85","author":"Arcaini","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0500","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dld.2010.05.010","article-title":"HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens","volume":"43","author":"Marignani","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0505","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2012.1883","article-title":"Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience","volume":"28","author":"Nishikawa","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0510","first-page":"20","article-title":"Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era","author":"Zaky","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.critrevonc.2014.10.008_bib0515","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-014-2138-5","article-title":"Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy","author":"Salah-Eldin","year":"2014","journal-title":"Ann Hematol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842814001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842814001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T07:50:16Z","timestamp":1717487416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842814001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1040842814001681"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2014.10.008","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}